CRVL vs CNC vs MOH Stock Comparison

Corvel, Centene and Molina Healthcare Prices as of Nov 13, 2026 Peers: Industry group
CRVL Corvel Corp
$85.69 +6.6% 1M +16.6% 1Y
Market cap
$4.39B
P/E
36.1x
Revenue (TTM)
$1.01B
Div. yield
–
Managed Care Healthcare
4 wins
CNC Centene Corp
$71.26 +1.6% 1M +97.5% 1Y
Market cap
$36.77B
P/E
–
Revenue (TTM)
$194.78B
Div. yield
–
Managed Care Healthcare
4 wins
MOH Molina Healthcare, Inc.
$209.62 +0.3% 1M +51.4% 1Y
Market cap
$11.69B
P/E
–
Revenue (TTM)
$44.13B
Div. yield
–
Managed Care Healthcare
2 wins

Head to Head

10 decided of 12

Centene leads on 4 of the 12 questions below (Centene 4, Corvel 4, Molina Healthcare 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCRVLCNCMOHLeader
Larger companyMarket capitalisation $4.39B $36.77B $11.69B CNC
Cheaper on earningsLower P/E, profitable companies only 36.1x -5.5x -243.5x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — 13.1x 41.0x CNC
Faster revenue growthRevenue growth, trailing twelve months +8.3% +19.4% -0.9% CNC
More profitableNet margin, trailing twelve months 12.0% -3.4% -0.1% CRVL
Better return on capitalReturn on invested capital — -19.9% 2.2% MOH
Less leveragedLower net debt / EBITDA — 0.0x -14.4x MOH
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +16.6% +97.5% +51.4% CNC
Better 5-year returnAnnualised price return, 5 years +6.0%/yr -1.2%/yr -7.7%/yr CRVL
Less volatileAnnualised volatility, 1 year 44.1% 46.4% 52.5% CRVL
Higher overall scoreMean of the five percentile scores vs peers 64/100 51/100 36/100 CRVL

Percentile Scorecard

CRVLCNCMOH

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCRVLCNCMOH
Valuation 27 #20 of 27 92 #3 of 27 42 #16 of 27
Growth 60 #11 of 26 28 #19 of 26 4 #25 of 26
Profitability 92 #3 of 26 36 #17 of 26 32 #18 of 26
Financial Health 96 #2 of 26 36 #17 of 26 64 #10 of 26
Shareholder Returns 47 #10 of 18 65 #7 of 18 –
Overall 64 51 36
  • CRVL ranked among 27 companies in Healthcare Payers and Distributors
  • CNC ranked among 27 companies in Healthcare Payers and Distributors
  • MOH ranked among 27 companies in Healthcare Payers and Distributors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCRVLCNCMOHSPY
1 month +6.6%+1.6%+0.3% -2.0%
3 months +30.4%+5.6%-1.3% -2.8%
6 months +50.0%+22.3%+13.3% +2.0%
Year to date +26.6%+73.2%+20.8% +10.6%
1 year +16.6%+97.5%+51.4% +12.2%
3 years +20.0%-2.7%-42.2% +68.1%
3 years, per year +6.3%-0.9%-16.7% +18.9%
5 years +34.0%-6.1%-33.1% +61.4%
5 years, per year +6.0%-1.2%-7.7% +10.1%
10 years +703.3%+181.2%+341.0% +248.5%
10 years, per year +23.2%+10.9%+16.0% +13.3%

Risk

MeasureCRVLCNCMOHSPY
Volatility, 1Y 44.1%46.4%52.5% 13.6%
Downside volatility, 1Y 53.6%45.1%57.9% 13.9%
Beta vs S&P 500, 1Y 0.060.46-0.01 1.00
Return / volatility, 1Y 0.382.100.98 0.90
Max drawdown, 5Y -64.2%-74.1%-70.8% -25.4%
From 52-week high -1.9%-6.2%-13.7% -3.2%
52-week high $87.38$75.99$242.88 $779.14
52-week low $46.00$31.80$122.65 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCRVLCNCMOH
P/E now vs peer median 35.6xmedian 25.2x -5.3xmedian 25.2x -223.6xmedian 25.2x
P/S now vs peer median 4.3xmedian 0.4x 0.2xmedian 0.4x 0.2xmedian 0.4x
EV/EBITDA now vs peer median 20.7xmedian 14.5x 0.2xmedian 14.5x 18.3xmedian 14.5x
P/FCF now vs peer median 33.8xmedian 16.5x 8.1xmedian 16.5x 45.8xmedian 16.5x
P/B now vs peer median 10.0xmedian 2.7x 1.7xmedian 2.7x 2.6xmedian 2.7x
PEG now vs peer median 1.91median 1.72 0.05median 1.72 8.22median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCRVLCNCMOH
Revenue $1.01B $194.78B $44.13B
Gross profit $258.02M $37.08B $5.56B
Operating income $161.13M -$7.62B $172.00M
Net income $121.52M -$6.68B -$48.00M
Free cash flow $127.86M $4.32B $238.00M
EPS (diluted) $2.40 $-13.53 $-0.93
Cash & equivalents $269.99M $17.89B $4.48B
Total debt – $17.40B $3.77B
Shares (diluted) 50.69M 493.12M 51.50M
Enterprise value $3.40B -$37.35B -$23.31B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCRVLCNCMOH
P/E 35.6x -5.3x -223.6x
P/FCF 33.8x 8.1x 45.8x
P/Operating cash flow 26.2x 6.9x 32.9x
P/S 4.3x 0.2x 0.2x
P/B 10.0x 1.7x 2.6x
P/Tangible book 10.0x 2.3x 2.6x
EV/EBITDA 20.7x 0.2x 18.3x
EV/EBIT 25.1x -4.2x 35.4x
EV/Revenue 4.0x 0.2x 0.1x
EV/FCF 31.7x 7.4x 25.6x
EV/Operating cash flow 24.5x 6.3x 18.4x
PEG (3Y EPS CAGR) 1.91 0.05 8.22

Growth

14 metrics
MetricCRVLCNCMOH
Revenue growth (1Y) 8.3% 19.4% -0.9%
Revenue CAGR (3Y) 10.4% 10.5% 9.9%
Gross profit growth (1Y) 14.2% -0.8% -10.2%
Gross profit CAGR (3Y) 15.3% 3.9% 3.3%
Operating income growth (1Y) 19.1% -340.1% -87.0%
Operating income CAGR (3Y) 19.3% -98.2% -49.8%
Net income growth (1Y) 15.4% -302.0% -105.4%
Net income CAGR (3Y) 17.6% -96.3% -27.1%
EPS growth (1Y) 17.7% -314.5% -105.5%
EPS CAGR (3Y) 18.6% -104.5% -27.2%
Operating cash flow growth (1Y) 14.2% 3,204% 171.8%
Operating cash flow CAGR (3Y) 19.3% -6.7% -46.3%
Free cash flow growth (1Y) 26.4% 981.8% 141.5%
Free cash flow CAGR (3Y) 21.1% -6.3% -51.1%

Profitability

14 metrics
MetricCRVLCNCMOH
Gross margin 25.5% 19.0% 12.6%
EBITDA margin 19.3% 84.8% 0.8%
Operating margin 15.9% -3.9% 0.4%
Pretax margin 15.9% -3.5% -0.1%
Net margin 12.0% -3.4% -0.1%
FCF margin 12.6% 2.2% 0.5%
Operating cash flow margin 16.3% 2.6% 0.8%
Return on equity 29.0% -32.5% -1.2%
Return on assets 17.3% -8.4% -0.3%
Return on invested capital – -19.9% 2.2%
Return on capital employed 36.3% -17.9% 2.0%
Asset turnover 1.4x 2.5x 2.8x
Cash conversion (OCF / net income) 1.4x -0.8x -6.9x
Stock comp / revenue 0.5% 0.1% 0.2%

Financial Health

11 metrics
MetricCRVLCNCMOH
Debt / assets – 22.7% 24.1%
Debt / equity – 0.9x 0.9x
Net debt / EBITDA – 0.0x -14.4x
Debt / FCF – 4.0x 15.8x
Liabilities / assets 39.7% 73.9% 73.5%
Equity / assets 60.3% 26.1% 26.5%
Interest coverage – -11.2x 0.8x
Current ratio 2.0x 1.1x 1.7x
Quick ratio 1.6x 1.0x 1.6x
Cash ratio 1.0x 0.6x 1.2x
Altman Z-score 13.88 2.80 4.15

Shareholder Returns

7 metrics
MetricCRVLCNCMOH
Dividend yield – – –
Net buyback yield 0.7% 1.2% –
Shareholder yield 0.7% 1.2% –
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCRVLCNCMOH
Forward P/E – 13.1xFY2026 41.0xFY2026
EPS, next fiscal year – $5.44FY2026 $5.11FY2026
EPS growth, next FY – +161.5%FY2026 -53.7%FY2026
EPS growth, the year after – +8.1% +93.0%
Revenue, next fiscal year – $206.34BFY2026 $41.59BFY2026
Revenue growth, next FY – +5.9%FY2026 -8.5%FY2026
Revenue growth, the year after – -1.2% +20.4%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCRVLCNCMOH
Held by institutions 54.5% 97.9% 100.0%
Institutions holding 288 1,001 600
Change in shares held, QoQ +2.3% +2.1% +1.2%
Institutions buying 172 569 364
Institutions selling 72 334 170
Buyers to sellers 2.39 1.70 2.14

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CRVLCNCMOH
CRVL 1.00 0.24 0.14
CNC 0.24 1.00 0.57
MOH 0.14 0.57 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CRVL, CNC and MOH?

Centene (CNC) is the largest by market capitalisation: Corvel (CRVL) $4.39B, Centene (CNC) $36.77B, Molina Healthcare (MOH) $11.69B.

Which company is growing faster?

Centene (CNC) grew revenue fastest over the trailing twelve months: Corvel (CRVL) +8.3%, Centene (CNC) +19.4%, Molina Healthcare (MOH) -0.9%.

Which company is more profitable?

Corvel (CRVL) has the highest net margin (Corvel (CRVL) 12.0%, Centene (CNC) -3.4%, Molina Healthcare (MOH) -0.1%). On return on invested capital, Molina Healthcare (MOH) leads (Centene (CNC) -19.9%, Molina Healthcare (MOH) 2.2%).

Which stock has performed better?

Over the past year Centene (CNC) returned the most: Corvel (CRVL) +16.6%, Centene (CNC) +97.5%, Molina Healthcare (MOH) +51.4%. Over five years, Corvel (CRVL) compounded fastest (Corvel (CRVL) +6.0%/yr, Centene (CNC) -1.2%/yr, Molina Healthcare (MOH) -7.7%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Corvel (CRVL) has been the steadiest (Corvel (CRVL) 44.1%, Centene (CNC) 46.4%, Molina Healthcare (MOH) 52.5%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CRVL, CNC and MOH?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Centene (CNC) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.